(Q37128676)

18 August 2017

1 reference

title

Obesity-related changes in high-density lipoprotein metabolism (English)

1 reference

18 August 2017

0 references

1 reference

Arshag D Mooradian

1

1 reference

18 August 2017

Michael J Haas

series ordinal

2

1 reference

18 August 2017

Kent R Wehmeier

series ordinal

3

1 reference

18 August 2017

Norman C W Wong

series ordinal

4

1 reference

18 August 2017

publication date

3 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

16

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

1152-1160

1 reference

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Differential effect of National Cholesterol Education Program (NCEP) Step II diet on HDL cholesterol, its subfractions, and apoprotein A-I levels in hypercholesterolemic women and men after 1 year: the beFIT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

A prospective study of obesity and risk of coronary heart disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Cardiovascular morbidity and mortality associated with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Prevalence of risk factors in men with premature coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Insulin resistance and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The triglyceride-high-density lipoprotein axis: an important target of therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Transcriptional control of apolipoprotein A-I gene expression in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Familial dyslipidaemias: an overview of genetics, pathophysiology and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effect of torcetrapib on the progression of coronary atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

HDL: the metabolism, function, and therapeutic importance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Mechanisms of disease: proatherogenic HDL--an evolving field

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Multiple risk factors for cardiovascular disease and diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Body mass index and the prevalence of hypertension and dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Low serum high-density lipoprotein cholesterol in obese subjects with normal serum triglycerides: the role of insulin resistance and inflammatory cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effects of glucose and insulin on rat apolipoprotein A-I gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Insulin induction of apolipoprotein AI, role of Sp1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Apolipoprotein A-I expression in rats is not altered by troglitazone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Apolipoprotein A1 expression in young and aged rats is modulated by dietary carbohydrates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Obesity: a rational target for managing diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Induction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Monosaccharide-enriched diets cause hyperleptinemia without hypophagia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Serum leptin response to endogenous hyperinsulinemia in aging rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Plasma lipoproteins and lipase and lecithin:cholesterol acyltransferase activities in obese subjects before and after weight reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary and genetic probes of atherogenic dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Influence of glycemic load on HDL cholesterol in youth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary fats differentially modulate the expression of lecithin:cholesterol acyltransferase, apoprotein-A1 and scavenger receptor b1 in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary fat saturation affects apolipoprotein AII levels and HDL composition in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Men and Women Differ in Lipoprotein Response to Dietary Saturated Fat and Cholesterol Restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

n-3 fatty acids and lipoproteins: comparison of results from human and animal studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Thematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Dietary protein type and cardiovascular disease risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Negative regulation of Apo A-I gene expression by retinoic acid in rat hepatocytes maintained in a coculture system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Effect of ethanol on lipoprotein secretion in two human hepatoma cell lines, HepG2 and Hep3B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

The relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.202

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.202

1 reference

18 August 2017

1 reference